- Report
- September 2022
- 30 Pages
Global
From €3631EUR$3,995USD£3,109GBP
- Report
- September 2022
- 74 Pages
Global
From €3177EUR$3,495USD£2,720GBP
- Report
- July 2022
- 639 Pages
Global
From €2272EUR$2,500USD£1,946GBP
- Clinical Trials
- December 2021
- 283 Pages
Global
From €2272EUR$2,500USD£1,946GBP
- Report
- May 2018
- 127 Pages
Global
From €13630EUR$14,995USD£11,670GBP
- Report
- February 2025
- 29 Pages
Canada
From €4540EUR$4,995USD£3,888GBP
- Report
- February 2025
- 29 Pages
Germany
From €4540EUR$4,995USD£3,888GBP
- Clinical Trials
- January 2024
- 176 Pages
Global
From €2272EUR$2,500USD£1,946GBP
- Clinical Trials
- January 2024
- 257 Pages
Global
From €2272EUR$2,500USD£1,946GBP
- Report
- October 2023
- 68 Pages
Global
From €9085EUR$9,995USD£7,779GBP
- Report
- October 2023
- 105 Pages
Global
From €2272EUR$2,500USD£1,946GBP
- Report
- October 2023
- 74 Pages
Global
From €3177EUR$3,495USD£2,720GBP
- Report
- October 2023
- 65 Pages
Global
From €3177EUR$3,495USD£2,720GBP
- Report
- September 2023
- 369 Pages
Global
From €2272EUR$2,500USD£1,946GBP
- Report
- July 2023
- 80 Pages
Global
From €3177EUR$3,495USD£2,720GBP
- Report
- July 2023
- 70 Pages
Global
From €3177EUR$3,495USD£2,720GBP
- Report
- June 2023
- 85 Pages
Global
From €2272EUR$2,500USD£1,946GBP
- Drug Pipelines
- May 2023
- 151 Pages
Global
From €13630EUR$14,995USD£11,670GBP
- Report
- May 2023
- 67 Pages
Global
From €3177EUR$3,495USD£2,720GBP
- Report
- April 2023
- 231 Pages
Global
From €2272EUR$2,500USD£1,946GBP

The Central Nervous System Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs that target the central nervous system. These drugs are used to treat a variety of conditions, including neurological disorders, mental health issues, and pain management. The market is composed of a variety of companies, ranging from large multinationals to small start-ups.
The Central Nervous System Drugs market is highly competitive, with companies competing to develop the most effective and safe treatments. Companies in the market are constantly researching and developing new drugs, as well as improving existing treatments. Many of these companies are also involved in clinical trials to test the safety and efficacy of their products.
Some of the major companies in the Central Nervous System Drugs market include Pfizer, GlaxoSmithKline, Merck, Novartis, and Johnson & Johnson. These companies are involved in the development and production of a wide range of CNS drugs, including antidepressants, antipsychotics, and anticonvulsants. Show Less Read more